COCONUT Study Concomitant PVI and LAAC
The COCONUT study is investigating a new approach for people with atrial fibrillation (AF), which is an irregular and often very rapid heart rhythm. These patients are often at a higher risk of stroke and might not be able to take blood-thinning medicines long-term. This study looks at combining two procedures, Pulmonary Vein Isolation (PVI) and Left Atrial Appendage Closure (LAAC), into one operation. Both procedures are usually done separately but involve a similar approach to the heart. The study uses a newer technique called Pulsed Field Ablation (PFA) for PVI, which might make the combined procedure quicker and safer. Researchers are collecting information worldwide to see how safe and effective this combined treatment is for patients.
At a glance
What is this study about?
This study, called COCONUT, is looking at a new way to treat people who have a common heart condition called atrial fibrillation, or AF. With AF, the heart beats irregularly, which can increase the risk of having a stroke. Many people with AF take blood-thinning medicines to reduce this stroke risk, but some can't take these medicines long-term, perhaps because they have a high risk of bleeding. For these people, another procedure called Left Atrial Appendage Closure (LAAC) can help reduce the stroke risk.
Separately, another important treatment for AF is called Pulmonary Vein Isolation (PVI). This procedure helps to correct the electrical signals in the heart that cause the irregular heartbeat. Both PVI and LAAC are usually done as separate operations, but they both involve working in the same area of the heart, called the left atrium, and use similar entry points.
The COCONUT study is investigating if combining these two procedures – PVI and LAAC – into one operation could be a good idea for patients. They are using a newer, gentler way to perform PVI called Pulsed Field Ablation (PFA), which experts believe might make the combined procedure quicker and safer. By looking at information from many patients globally, the study aims to understand if this combined approach is safe, effective, and efficient. If successful, it could mean a better treatment option for some AF patients, potentially reducing the need for long-term blood thinners and possibly even reducing the overall number of procedures they need.
Key takeaways
- The COCONUT study looks at combining two heart procedures for AF patients.
- It aims to see if PVI and LAAC can be done together safely and effectively.
- A new technique called PFA is used for PVI, potentially making it quicker.
- This could offer a better option for AF patients at high stroke risk.
- It might reduce the need for long-term blood thinners in some patients.
Who may be eligible?
To be considered for inclusion in this study, you would need to have both: an established medical reason (an 'indication') for undergoing Pulmonary Vein Isolation (PVI) and an established medical reason for undergoing Left Atrial Appendage Closure (LAAC). This means your doctors would have already determined that both of these procedures are appropriate for your specific heart condition.
You would not be eligible to take part if you are medically unable to have either of the procedures (PVI or LAAC). Essentially, if your doctor has advised against one or both of these procedures because of other health reasons or risks, then this study would not be suitable for you. The study is open to both men and women of any adult age.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Do I have Atrial Fibrillation (AF)?
- Has my doctor said I need a PVI procedure?
- Has my doctor said I need an LAAC procedure?
- Am I generally considered well enough for both procedures?
What does participation involve?
This study is a 'registry study,' which means researchers are collecting information about patients who have already had these combined procedures as part of their routine care, rather than asking people to undergo new and experimental treatments. So, you wouldn't be asked to change any part of your treatment plan specifically for the study. Instead, researchers would gather details about your health, the procedures you had, and how you recovered, from your existing medical records. There might be follow-up appointments, but these would likely be the standard ones you would have anyway after these procedures. The total duration of your participation would depend on how long your doctor typically monitors your health after these treatments.
Potential risks and benefits
Locations (1)
- Asklepios Klinik AltonaVerified postcodeHamburg, Germany· Recruiting
Common questions
What is Atrial Fibrillation (AF)?
AF is an irregular heartbeat that can increase your risk of stroke. It's one of the most common types of heart rhythm problems.
What do PVI and LAAC mean?
PVI (Pulmonary Vein Isolation) is a procedure to fix the irregular heart rhythm. LAAC (Left Atrial Appendage Closure) helps reduce stroke risk for people who can't take blood thinners.
Why combine these two procedures?
Combining them might mean you only need one operation instead of two, potentially making it quicker and safer, especially with new techniques like PFA.
What is Pulsed Field Ablation (PFA)?
PFA is a newer, gentler way to perform the PVI procedure, which uses electrical pulses to treat the heart tissue. It might be safer and lead to shorter procedure times.
Will I have to do anything differently if I participate?
No, this is a 'registry study,' meaning researchers are simply collecting information from your existing medical records if you've already had these procedures as part of your normal care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.